46% power in study planning? [Study As­sess­ment]

posted by sam – India, 2013-08-02 09:00 (4714 d 20:16 ago) – Posting: # 11160
Views: 30,769

Hi John

❝ If outlier test confirms then one option is to do a rechallenge study -> Run another small study with the questionable subjects along with a few controls.


Will the USFDA accept the data after exclusion of the subjects if the re-dosing confirms the outlier.

Regards

Sam

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
309 visitors (0 registered, 309 guests [including 28 identified bots]).
Forum time: 05:17 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5